Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07520175 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study of Outcomes Following Bio-Reinforced Canaloplasty in Eyes With Open-Angle Glaucoma

Study acronym: BOOST
StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 7 to 9
    • Eligibility criteria revised
  2. Study sites revised (7)
    • Study description shortened, about 4 words
    v5
  3. Study sites: 5 to 7v4
  4. Study sites: 3 to 5v3
  5. Study sites: 1 to 3v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this study is to learn about outcomes after bio-reinforced canaloplasty surgery in patients with OAG. The key question the study aims to answer is: How much does the surgical procedure lower pressure inside the eye and what is the durability of this effect? Participants will return for periodic eye exams for 2 years following surgery.
Trial Details
NCT Number NCT07520175
Lead Sponsor Iantrek, Inc.
Conditions
(from sponsor)		 Open-Angle Glaucoma
Related terms Glaucoma, Open-Angle
Enrollment 300 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov